Problem opioid use and HIV primary care engagement among hospitalized people who use drugs and/or alcohol
暂无分享,去创建一个
C. del Rio | L. Metsch | D. Feaster | R. Mandler | A. Carrico | Petra Jacobs | Allan E. Rodriguez | L. Critchley | N. Gukasyan | Natalie Gukasyan
[1] P. Seth,et al. Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018 , 2020, MMWR. Morbidity and mortality weekly report.
[2] Ellsworth M. Campbell,et al. Opioid Use Fueling HIV Transmission in an Urban Setting: An Outbreak of HIV Infection Among People Who Inject Drugs-Massachusetts, 2015-2018. , 2019, American journal of public health.
[3] A. Fauci,et al. Opioids and Infectious Diseases: A Converging Public Health Crisis. , 2019, The Journal of infectious diseases.
[4] Robert W Eisinger,et al. HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. , 2019, JAMA.
[5] W. Schaffner,et al. Long-acting Opioid Use and the Risk of Serious Infections: A Retrospective Cohort Study. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] W. Miller,et al. Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C , 2018, Current HIV/AIDS Reports.
[7] Sarah J. Reed,et al. An Exploration of Syndemic Factors That Influence Engagement in HIV Care Among Black Men , 2018, Qualitative health research.
[8] Lawrence Scholl,et al. Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017 , 2018, MMWR. Morbidity and mortality weekly report.
[9] Publisher's Note , 2018, Anaesthesia.
[10] D. Lewer,et al. Opiate Injection–Associated Skin, Soft Tissue, and Vascular Infections, England, UK, 1997–2016 , 2017, Emerging infectious diseases.
[11] T. Heeren,et al. HIV-infected individuals who use alcohol and other drugs, and virologic suppression , 2017, AIDS care.
[12] K. Ruggles,et al. Sexual Risk and Transmission Behaviors, Partnerships and Settings Among Young Adult Nonmedical Opioid Users in New York City , 2017, AIDS and Behavior.
[13] Michael W. Spiller,et al. HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015. , 2016, The New England journal of medicine.
[14] C. del Rio,et al. Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial. , 2016, JAMA.
[15] G. Bobashev,et al. Event-level analyses of sex-risk and injection-risk behaviors among nonmedical prescription opioid users , 2016, The American journal of drug and alcohol abuse.
[16] A. Karchmer,et al. Suboptimal Addiction Interventions for Patients Hospitalized with Injection Drug Use-Associated Infective Endocarditis. , 2016, The American journal of medicine.
[17] R. Durvasula,et al. Substance Abuse Treatment in Persons with HIV/AIDS: Challenges in Managing Triple Diagnosis , 2014, Behavioral medicine.
[18] F. Altice,et al. Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] J. Montaner,et al. Barriers to HIV treatment among people who use injection drugs: implications for ‘treatment as prevention’ , 2012, Current opinion in HIV and AIDS.
[20] G. Woody,et al. Addiction Severity Index , 2012 .
[21] S. Strathdee,et al. Adherence to Antiretroviral Therapy Among HIV-Infected Drug Users: A Meta-Analysis , 2010, AIDS and Behavior.
[22] D. Shepard,et al. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward , 2010, The Lancet.
[23] V. Soriano,et al. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs , 2010, The Lancet.
[24] Robert J. Volk,et al. Effectiveness of the AUDIT-C as a Screening Test for Alcohol Misuse in Three Race/Ethnic Groups , 2008, Journal of General Internal Medicine.
[25] C. Cunningham,et al. Barriers to Obtaining Waivers to Prescribe Buprenorphine for Opioid Addiction Treatment Among HIV Physicians , 2007, Journal of General Internal Medicine.
[26] K. Lynch,et al. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence. , 2005, Archives of internal medicine.
[27] J. Enders,et al. Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.
[28] B. Oldfield,et al. Integration of care for HIV and opioid use disorder. , 2019, AIDS.